Skip to main content

Roland Kolbeck

Analyst

Equibles does not estimate personal net worth.

About Roland Kolbeck

Roland Kolbeck has spoken on 1 investor event across 1 company, most recently for Aclaris Therapeutics, Inc. on April 14, 2026. The companies whose calls Roland Kolbeck spoke on are classified in the Healthcare sector.

Roland Kolbeck on recent calls

“I can start talking a little bit about the distinction of the ITK-specific and the dual ITK-CHK3 inhibitor. So ATI-2138, that's our furthest advanced small molecule inhibitor.”
H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference ·

Company network

Recent activity